Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 4/20 | 0.56 |
| ▸ | HSP90B1 | P14625 | 2/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.51 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.51 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.51 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 3/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.51 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.51 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10687080 | 0.86 | ADORA3 (0.59) | AHCYHSP90B1ADORA3ADORA2BADORA2A | |
| SCHEMBL11421043 | 0.83 | AHCY (0.62) | AHCYHSP90B1ADORA3ADORA2BADORA2A | |
| SCHEMBL5685760 | 0.82 | AHCY (0.54) | AHCYHSP90B1ADORA3ADORA2BADORA2A | |
| SCHEMBL7924078 | 0.81 | AHCY (0.53) | AHCYHSP90B1ADORA3ADORA2BADORA2A | |
| SCHEMBL1093486 | 0.80 | EHMT1 (0.56) | AHCYADORA3ADORA2BADORA2AADORA1 | |
| SCHEMBL6692383 | 0.80 | AHCY (0.54) | AHCYADORA3ADORA2BADORA2AADORA1 | |
| SCHEMBL5354507 | 0.78 | ADORA3 (0.56) | AHCYHSP90B1ADORA3ADORA2BADORA2A | |
| SCHEMBL6697082 | 0.78 | AHCY (0.52) | AHCYADORA3ADORA2BADORA2AADORA1 | |
| SCHEMBL6695446 | 0.77 | AHCY (0.53) | AHCYHSP90B1ADORA3ADORA2BADORA2A | |
| SCHEMBL5349884 | 0.77 | HSP90B1 (0.57) | AHCYHSP90B1ADORA3ADORA2BADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050009776-A1 | Method of treating atrial fibrillation or atrial flutter | ADERIS PHARMACEUTICALS, INC. (US) | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009776-A1 | Method of treating atrial fibrillation or atrial flutter | ADORA2A, HCN3, SCN9A | AHCY 627/4885HSP90B1 3116/4885ADORA3 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.